NCT00121758View on ClinicalTrials.gov

AIDS Vaccine Study Comparing Immunogenicity and Safety of 3 Doses of Lipopeptides Versus Placebo in Non Infected HIV Volunteers

PHASE2CompletedINTERVENTIONAL

Enrollment

156

Participants

Timeline

Start Date

September 30, 2004

Primary Completion Date

November 30, 2007

Study Completion Date

December 31, 2007

Conditions

HIV Infections

Interventions

BIOLOGICAL

LIPO-5

Trial Locations (1)

75014

CIC de Vaccinologie Cochin Pasteur, Paris

Sponsors

Collaborators (1)

Aventis Pharmaceuticals

All Listed Sponsors

collaborator

Aventis Pharmaceuticals

INDUSTRY

lead

French National Agency for Research on AIDS and Viral Hepatitis

OTHER_GOV